Morgan Stanley (MS)

175.41
+1.04 (0.60%)
NYSE · Last Trade: Feb 20th, 5:38 PM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close174.37
Open173.45
Bid174.41
Ask175.41
Day's Range171.56 - 175.43
52 Week Range94.33 - 192.68
Volume4,268,351
Market Cap320.05B
PE Ratio (TTM)17.99
EPS (TTM)9.8
Dividend & Yield4.000 (2.28%)
1 Month Average Volume8,377,993

Chart

About Morgan Stanley (MS)

Morgan Stanley is a leading global financial services firm that provides a wide range of services in investment banking, securities, wealth management, and investment management. Catering to a diverse clientele that includes corporations, governments, and individuals, Morgan Stanley offers expert advisory and financing services, helping clients navigate complex financial markets and achieve their financial objectives. The firm is known for its strategic insights, innovative solutions, and commitment to delivering exceptional service, positioning itself as a trusted partner in the world of finance. Read More

News & Press Releases

The Warsh Doctrine: Trump’s Fed Pick Triggers a Seismic Shift in Global Markets
As of February 20, 2026, the global financial landscape is undergoing a fundamental transformation following President Donald Trump’s nomination of Kevin Warsh to succeed Jerome Powell as Chairman of the Federal Reserve. Announced on January 30 and slated for a formal transition in May 2026, the move marks the
Via MarketMinute · February 20, 2026
Stock Market Today, Feb. 20: CoreWeave Falls After Blue Owl Data Center Financing Failure Raises Funding Concernsfool.com
Today, Feb. 20, 2026, funding setbacks put CoreWeave's AI build-out strategy under the microscope.
Via The Motley Fool · February 20, 2026
CoreWeave Falls Below Key Support Levels Amid Hyperscaler Panic. Should You Buy the CRWV Stock Dip?
CoreWeave stock slips as Blue Owl Capital reportedly fails to secure debt financing for data center project. But Morgan Stanley cautions against buying CRWV shares on Feb. 20.
Via Barchart.com · February 20, 2026
The Dollar’s Wild Ride: Inside the 2026 Currency Volatility Reshaping Global Trade
The U.S. financial landscape is currently grappling with a "V-shaped" whipsaw in the value of the U.S. Dollar Index (DXY), a move that has caught both Wall Street analysts and corporate treasurers off guard. After plunging to a four-year low of 95.5 on January 30, 2026, the
Via MarketMinute · February 20, 2026
Morgan Stanley Initiates GE Aerospace Coverage With Top Price Targetinvestors.com
GE Aerospace will exceed Wall Street's consensus estimates for earnings and free cash flow through 2028, according to Morgan Stanley.
Via Investor's Business Daily · February 20, 2026
CoreWeave Stock Tumbles 12% — Analyst Flags Execution Risks Ahead Of Earningsstocktwits.com
According to a Barron’s report, Morgan Stanley assigned the cloud infrastructure provider an “Equal Weight” rating and set a $99 price target, suggesting only modest upside from recent levels.
Via Stocktwits · February 20, 2026
Trump’s “Central Casting” Choice: Kevin Warsh Nominated to Lead Federal Reserve into New Era
President Donald Trump has officially nominated former Federal Reserve Governor Kevin Warsh to succeed Jerome Powell as Chair of the Federal Reserve, a move that signals a seismic shift in American monetary policy. As Powell’s term approaches its May 2026 expiration, the selection of Warsh—a figure synonymous with
Via MarketMinute · February 20, 2026
Here's How Morgan Stanley Beats the Market From Herefool.com
Under certain market and economic conditions, Morgan Stanley's stock could rise even further.
Via The Motley Fool · February 20, 2026
Are Wall Street Analysts Predicting Martin Marietta Stock Will Climb or Sink?
Despite Martin Marietta's strong performance relative to the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook about the stock’s prospects.
Via Barchart.com · February 20, 2026
KLAR Stock Attempts Bounce After Record Crash – Morgan Stanley Urges ‘Meaningfully More Profitable’ Turnstocktwits.com
Wells Fargo and Morgan Stanley cut their target price on KLAR stock after the company posted a fourth-quarter net loss.
Via Stocktwits · February 20, 2026
Are Wall Street Analysts Bullish on West Pharmaceutical Services Stock?
West Pharmaceutical Services has outperformed the broader market over the past year, and analysts are highly optimistic about the stock’s prospects.
Via Barchart.com · February 20, 2026
GE Stock On Track To Hit All-Time High: Morgan Stanley Calls It A ‘Structural Winner’, Flags 27% Upsidestocktwits.com
Morgan Stanley initiated coverage of the stock with an ‘Overweight’ rating and a price target of $425, according to The Fly.
Via Stocktwits · February 20, 2026
Billionaire Philippe Laffont Sells Nvidia Stock and Buys a Stock-Split Stock Up 20,000% in 20 Yearsfool.com
Philippe Laffont, a hedge fund manager with an excellent track record, sold Nvidia and bought Netflix in the fourth quarter.
Via The Motley Fool · February 20, 2026
Amazon’s ‘Capex Shock’ Oversold? Morgan Stanley Calls Bottom as Tech Indicators Flash Rare Buy Signals
SEATTLE — After a tumultuous start to February 2026 that saw Amazon.com, Inc. (NASDAQ:AMZN) endure a record-tying nine-day losing streak, market technicals and top-tier analyst calls suggest the e-commerce and cloud giant has finally found a floor. Following a massive $200 billion capital expenditure announcement that initially spooked investors,
Via MarketMinute · February 19, 2026
Stay updated with the S&P500 stocks that are on the move in today's after-hours session.chartmill.com
Via Chartmill · February 19, 2026
$100 Invested In Morgan Stanley 10 Years Ago Would Be Worth This Much Todaybenzinga.com
Via Benzinga · February 19, 2026
Morgan Stanley Schedules Fourth Quarter and Full-Year 2026 Investor Conference Call
Morgan Stanley (NYSE: MS) will announce its fourth quarter and full-year 2026 financial results on Thursday, January 14, 2027, at approximately 7:30 a.m. (ET). A conference call to discuss the results will be held on January 14, 2027, at 9:30 a.m. (ET).
By Morgan Stanley · Via Business Wire · February 19, 2026
The Golden Age of M&A: How Goldman Sachs Reclaimed the Crown in a Record-Breaking 2025
As the financial world looks back on the transformative landscape of 2025, one institution stands head and shoulders above the rest. Goldman Sachs (NYSE: GS) has once again solidified its position as the preeminent force in global investment banking, orchestrating a dominant performance in a year defined by the return
Via MarketMinute · February 19, 2026
The Amazon Divide: Berkshire Hathaway Retreats as Morgan Stanley Bets on a GenAI Revolution
The investment landscape for Amazon.com, Inc. (NASDAQ: AMZN) has reached a striking crossroads this February 2026, as two of the market's most influential voices have taken diametrically opposed positions on the tech giant’s future. In a move that sent ripples through the financial community, Berkshire Hathaway Inc. (NYSE:
Via MarketMinute · February 19, 2026
Dow 50,000: Blue-Chips Surge as the 'Great Rotation' Rewrites the Market Playbook
The global financial landscape reached a historic milestone on February 6, 2026, when the Dow Jones Industrial Average (DJIA) breached the 50,000-point threshold for the first time in its 130-year history. Closing the session at 50,115.67, the index signaled a definitive shift in investor sentiment, marking a
Via MarketMinute · February 19, 2026
Wall Street's Middlemen: Why Capital Markets ETFs Are Winning in the M&A Boomfool.com
This unique financial services ETF could get a boost from rising mergers and acquisitions activity, but there's more to the story.
Via The Motley Fool · February 19, 2026
The Backbone of America: Why This Bank ETF Is a Must-Watch for Value Investorsfool.com
Investors looking for insights about the strength of the economy and a basket of value stocks might want to examine this bank ETF.
Via The Motley Fool · February 19, 2026
3 Stocks to Buy and Hold for 2026 and Beyondfool.com
Any of these three pharmaceutical titans could move the needle in your portfolio.
Via The Motley Fool · February 19, 2026
CRISPR Therapeutics Gains After Earnings as Pipeline Hope Growsmarketbeat.com
Via MarketBeat · February 19, 2026
Figma Q4 Results Beat Street Expectations, So Why Are Analysts Slashing Targets?stocktwits.com
RBC Capital lowered its target on Figma to $31 from $38 and kept a ‘Sector Perform’ rating on the shares, according to TheFly.
Via Stocktwits · February 19, 2026